Sample Size Computations for PK/PD Population Models
暂无分享,去创建一个
[1] A. Wald. Tests of statistical hypotheses concerning several parameters when the number of observations is large , 1943 .
[2] J Rochon,et al. Application of GEE procedures for sample size calculations in repeated measures experiments. , 1997, Statistics in medicine.
[3] France Mentré,et al. Optimization of Individual and Population Designs Using Splus , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[4] K. Lui. Sample sizes for repeated measurements in dichotomous data. , 1991, Statistics in medicine.
[5] K. Lui. Sample Size Determination for Repeated Measurements in Bioequivalence Test , 1997, Journal of Pharmacokinetics and Biopharmaceutics.
[6] Dongwoo Kang,et al. A sample size computation method for non‐linear mixed effects models with applications to pharmacokinetics models , 2004, Statistics in medicine.
[7] L Aarons,et al. Population pharmacokinetics of tobramycin. , 1989, British journal of clinical pharmacology.
[8] D. Abernethy,et al. Verapamil pharmacodynamics and disposition in young and elderly hypertensive patients. Altered electrocardiographic and hypotensive responses. , 1986, Annals of internal medicine.
[9] M A Schork,et al. Sample sizes in the multivariate analysis of repeated measurements. , 1986, Biometrics.
[10] Mats O. Karlsson,et al. Assessment of Type I Error Rates for the Statistical Sub-model in NONMEM , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[11] S. Akselrod,et al. Hemodynamic regulation in SHR: investigation by spectral analysis. , 1987, The American journal of physiology.
[12] L Pronzato,et al. Optimal experiment design for nonlinear models subject to large prior uncertainties. , 1987, The American journal of physiology.
[13] D. Bloch,et al. Sample size requirements and the cost of a randomized clinical trial with repeated measurements. , 1986, Statistics in medicine.
[14] S. Gupta,et al. Population analyses of sustained‐release verapamil in patients: Effects of sex, race, and smoking , 2003, Clinical pharmacology and therapeutics.
[15] G. Segre,et al. Kinetics of interaction between drugs and biological systems. , 1968, Il Farmaco; edizione scientifica.
[16] Eric R. Ziegel,et al. Practical Nonparametric and Semiparametric Bayesian Statistics , 1998, Technometrics.
[17] Claudio Cobelli,et al. Identifiability of compartmental systems and related structural properties , 1979 .
[18] S. Chow,et al. On Sample Size Calculation in Bioequivalence Trials , 2001, Journal of Pharmacokinetics and Pharmacodynamics.
[19] W. Cumberland,et al. Sample size requirement for repeated measurements in continuous data. , 1992, Statistics in medicine.
[20] Varun Garg,et al. Comparison of four basic models of indirect pharmacodynamic responses , 1993, Journal of Pharmacokinetics and Biopharmaceutics.
[21] France Mentré,et al. Robust Optimal Design for the Estimation of Hyperparameters in Population Pharmacokinetics , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[22] J. Jacquez,et al. Numerical parameter identifiability and estimability: Integrating identifiability, estimability, and optimal sampling design , 1985 .
[23] D Verotta,et al. Concepts, properties, and applications of linear systems to describe distribution, identify input, and control endogenous substances and drugs in biological systems. , 1996, Critical reviews in biomedical engineering.